Has David Kaufman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $785,478 in general payments to David Kaufman, MD across 1,422 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Kaufman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Kaufman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Kaufman, MD

Allergy & Immunology · Shreveport, LANPI 1164482725

Payments from drug & device makers

$785,478in general payments, 2019–2025

Across 1,422 payments — averaging $552.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Takeda Pharmaceuticals U.S.A., Inc.$192K
GSK$161K
Biocryst US Sales Co., LLC$103K
Regeneron Healthcare Solutions, Inc.$89K
Blueprint Medicines Corporation$66K
Shire North American Group Inc$33K
plus $141K from 38 others

$2,451in research payments, 2019–2025

Across 18 payments — averaging $136.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

GSK$2K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Takeda Pharmaceuticals U.S.A., Inc.	235	$192,421
GSK	236	$161,479
Biocryst US Sales Co., LLC	131	$103,227
Regeneron Healthcare Solutions, Inc.	156	$88,549
Blueprint Medicines Corporation	89	$65,664
Shire North American Group Inc	68	$32,855
Sanofi US Services Inc.	27	$31,535
Ionis Pharmaceuticals, Inc.	23	$22,436
Merck	17	$18,480
AstraZeneca	132	$16,064
Astrazeneca UK Limited	2	$9,930
Biocryst Pharmaceuticals, Inc.	14	$7,789
Novartis	26	$7,410
CSL Behring	17	$7,205
Sanofi	34	$6,929
Alk-abello, Inc	12	$6,769
Pharming Healthcare, Inc.	14	$2,698
Genentech USA, Inc.	39	$644
Amgen(2 entities)	30	$637
Boehringer Ingelheim	24	$394
Grifols USA, LLC	12	$318
Sanofi-aventis U.S. LLC	13	$307
Motiva USA, LLC	1	$225
Kaleo, Inc.	9	$213
LEO Pharma Inc.	8	$166
Incyte Corporation	2	$156
Verona Pharma, Inc.	7	$140
Aimmune Therapeutics, Inc.	5	$126
ARS Pharmaceuticals Operations, Inc.	5	$94
Teva Pharmaceuticals USA, Inc.	6	$84
Lilly USA, LLC	4	$67
Inogen, Inc.	4	$65
Pfizer	4	$64
Greer Laboratories, Inc.	3	$55
Organon	2	$45
Octapharma USA, Inc.	1	$43
Inspire Medical Systems, Inc.	1	$37
Intersect ENT, Inc.	2	$27
Shionogi Inc	1	$27
Aytu Biopharma, Inc.	2	$27
Itamar Medical Inc	1	$22
Electromed, Inc.	1	$21
Galderma Laboratories, L.p.	1	$19
Hospira, Inc.	1	$14

How this compares

$785,478 in reported general payments places this provider in the 95th percentile of 62 allergy & immunology providers in Louisiana.

See all allergy & immunology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$16,456

Medicare patients

Services billed

1,193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Shreveport

Caroline CapertonShreveport$52K
Anand BhatShreveport$9K
Gonzalo Alvarez del RealShreveport$8K
Lori JohnsonShreveport$5K
Hannah FucinariShreveport$4K
Andria CheramieShreveport$3K
Priyal UpadhyayShreveport$2K
Steven WhitedShreveport$451
Jibran AtwiLafayette$9.7M
Kenneth ParisNew Orleans$266K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →